Curis Management

Management criteria checks 3/4

Curis' CEO is Jim Dentzer, appointed in Sep 2018, has a tenure of 6.25 years. total yearly compensation is $1.66M, comprised of 38.1% salary and 61.9% bonuses, including company stock and options. directly owns 0.072% of the company’s shares, worth €18.01K. The average tenure of the management team and the board of directors is 5.3 years and 10.4 years respectively.

Key information

Jim Dentzer

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage38.1%
CEO tenure6.3yrs
CEO ownership0.07%
Management average tenure5.3yrs
Board average tenure10.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jim Dentzer's remuneration changed compared to Curis's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$45m

Jun 30 2024n/an/a

-US$48m

Mar 31 2024n/an/a

-US$48m

Dec 31 2023US$2mUS$634k

-US$47m

Sep 30 2023n/an/a

-US$47m

Jun 30 2023n/an/a

-US$48m

Mar 31 2023n/an/a

-US$52m

Dec 31 2022US$3mUS$615k

-US$57m

Sep 30 2022n/an/a

-US$59m

Jun 30 2022n/an/a

-US$57m

Mar 31 2022n/an/a

-US$52m

Dec 31 2021US$3mUS$590k

-US$45m

Sep 30 2021n/an/a

-US$39m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$2mUS$545k

-US$30m

Sep 30 2020n/an/a

-US$31m

Jun 30 2020n/an/a

-US$31m

Mar 31 2020n/an/a

-US$32m

Dec 31 2019US$2mUS$510k

-US$32m

Sep 30 2019n/an/a

-US$29m

Jun 30 2019n/an/a

-US$30m

Mar 31 2019n/an/a

-US$32m

Dec 31 2018US$2mUS$479k

-US$33m

Sep 30 2018n/an/a

-US$35m

Jun 30 2018n/an/a

-US$43m

Mar 31 2018n/an/a

-US$48m

Dec 31 2017US$2mUS$443k

-US$53m

Compensation vs Market: Jim's total compensation ($USD1.66M) is above average for companies of similar size in the German market ($USD469.36K).

Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.


CEO

Jim Dentzer (57 yo)

6.3yrs

Tenure

US$1,662,978

Compensation

Mr. James E. Dentzer, also known as Jim, serves as Independent Director of Imunon, Inc. since September 2022. He serves as President, Chief Executive Officer & Director since September 24, 2018 and Secreta...


Leadership Team

NamePositionTenureCompensationOwnership
James Dentzer
President6.3yrsUS$1.66m0.072%
€ 18.0k
Diantha Duvall
CFO and Principal Financial & Accounting Officer2.3yrsUS$1.01m0.0076%
€ 1.9k
Jonathan Zung
Chief Development Officer1.6yrsUS$1.04m0%
€ 0
Mark Noel
Vice President of Technology Management & Intellectual Property16.3yrsUS$413.39kno data
Robert Martell
Chief Scientific Officerno dataUS$1.17mno data
Elif McDonald
VP of Investor Relations & Corporate Communicationsno datano datano data
Reinhard von Roemeling
Senior Vice President of Clinical Development5.3yrsno datano data

5.3yrs

Average Tenure

59yo

Average Age

Experienced Management: CUS0's management team is seasoned and experienced (5.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
James Dentzer
President6.3yrsUS$1.66m0.072%
€ 18.0k
Martyn Greenacre
Independent Chairman of the Board24.8yrsUS$158.70k0.015%
€ 3.9k
Marc Rubin
Independent Director14.5yrsUS$123.70k0.017%
€ 4.3k
Kenneth Kaitin
Independent Director21.1yrsUS$126.20k0.017%
€ 4.2k
John Hohneker
Independent Director3yrsUS$106.20k0%
€ 0
Anne Borgman-Hagey
Independent Director2.2yrsUS$103.70k0%
€ 0

10.4yrs

Average Tenure

66.5yo

Average Age

Experienced Board: CUS0's board of directors are seasoned and experienced ( 10.4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:47
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Curis, Inc. is covered by 27 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
James BirchenoughBMO Capital Markets Equity Research
Brian SkorneyBrean Capital